Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats.
A common action of chronic antidepressant treatments is the potentiation of dopaminergic transmission in the limbic system. We now report that chronic, but not acute, treatment with fluoxetine (2.5 mg/kg by intragastric gavage once a day for 21 days) potentiates the locomotor stimulant effect of quinpirole, a selective dopamine D2/D3 receptor agonist. However, neither quinpirole-induced stereotypies nor the sedative effects elicited by low doses of this dopamine receptor agonist are influenced by chronic fluoxetine. These results suggest that fluoxetine, as well as classical antidepressants, sensitize postsynaptic dopamine D2/D3 receptors in the mesolimbic system.
Collu
M
M
Department of Pharmacological Sciences, University of Sassari, Italy. mcollu@unica.it
Poggiu
A S
AS
Devoto
P
P
Serra
G
G
D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D005473:Fluoxetine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D019257:Quinpirole / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000819:agonists / Q000187:drug effects*; D013239:Stereotyped Behavior / Q000187:drug effects
D018687:Antidepressive Agents, Second-Generation; D017448:Receptors, Dopamine D2; D005473:Fluoxetine; D019257:Quinpirole